Abstract
Nanomaterials have gained tremendous significance as contrast agents for both anatomical and functional preclinical bio-imaging. Contrary to conventional medical practices, molecular imaging plays an important role in exploring the affected cells, thus providing precision medical solutions. It has been observed that incorporating nanoprobes improves the overall efficacy of the diagnosis and treatment processes. These nano-agents and tracers are therefore often incorporated into preclinical therapeutic and diagnostic applications. Multimodal imaging approaches are well equipped with nanoprobes to explore neurological disorders, as they can display more than one type of characteristic in molecular imaging. Multimodal imaging systems are explored by researchers as they can provide both anatomical and functional details of tumors and affected tissues. In this review, we present the state-of-the-art research concerning multimodal imaging systems and nanoprobes for neuroimaging applications.
Highlights
The success of medicine and healthcare is largely determined by the efficacy of treatment techniques
We provide a comprehensive overview of the nanoprobes/tracers used for neuroimaging applications and the context in which they are used, classified as per the multimodal combinations as Positron Emission Tomography (PET)-Computed Tomography (CT), PET-Magnetic Resonance Imaging (MRI) and Single-Photon Emission Computed Tomography (SPECT)-CT
This paper provided an overview of the latest developments in the field of multimodal neuroimaging using nanoprobes, in combination with functional and anatomical imaging
Summary
The success of medicine and healthcare is largely determined by the efficacy of treatment techniques. Imaging systems serve as an excellent diagnostic tool by capturing the details of the disease and therapeutic process on injecting bio-chemical agents or nanoprobes. Several imaging techniques have been developed over time to study the effects of therapeutic agents [6]. Images may be captured at different time intervals using different modalities within the asynchronous model of acquisition for which effective post-processing solutions should be developed. This marriage between therapeutics and diagnostics, as well as the choice of imaging systems, is greatly influenced by the design of the nano-imaging agents.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
